Performed to determine if plausible variations in the estimates of certain variables thought to be subject to significant uncertainty affect the results of the cost analysis may reveal, for example, that including indirect costs, or assuming the use of generic as opposed to brand name drugs in a medical therapy, or using a plausible higher discount rate in an analysis changes the cost-effectiveness of one intervention compared to another.